Pre vs Post Block in Total Knee Arthroplasty (TKA)
Key facts
- Who runs it
- University of Miami
- Where
- Miami, United StatesSee the site
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 84 people enrolled
- Started
- 29 Sept 2023
- Ended
- 22 Jan 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Dexamethasone
- Acetaminophen
- Lyrica
- Celebrex
- Meloxicam
- Oxycodone
- Ropivacaine
- Record updated
- 12 February 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- 1- Patients 18 or older 2 - Patients undergoing primary total knee replacement at the University of Miami Hospital 3 - Patients that have capacity to provide medical consent
Who cannot take part
- Patients with prior surgery or history of infection on the joint of interest
- Patients on steroid preoperatively
- Prisoners, uncontrolled diabetics, increased risk of bleeding, pregnant women, women planning on becoming pregnant in the next year, and women who think they might be pregnant
- Patients with a history of significant unmitigated pain in parts of their body not including the knee the procedure is to be performed or a history of pain catastrophizing (the tendency to magnify the threat value of the pain stimulus and to feel helpless in the context of pain, and by a relative inability to inhibit pain-related thoughts in anticipation of, during or following a painful event) regarding pain anywhere in the body
- Any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements will exclude the participant
- Allergy to local anesthetic or any medication used in the standard protocol for joint replacement
- All patients under the age of 18
- Inability to provide medical consent
Where in United States
- University of MiamiMiami, United States
About the trial
What the trial wants to find out
The purpose of this project is to determine if a change in patient reported pain, nausea and vomiting after total knee arthroplasty can be observed with the substitution of a post operative adductor canal block for a preoperative adductor canal block in the current established peri-operative pain protocol and if these changes lead to a decrease in opioid consumption (in morphine equivalents).
The 2 groups in the trial
- Preoperative Adductor Canal Block GroupExisting treatment, for comparison
Participants in this group will receive the standard of care treatment for pain management for TKA including a preoperative adductor canal block. Participants will be in this group for up to 24 hours after surgery.
Treatment: Dexamethasone, Acetaminophen, Lyrica, Celebrex, Meloxicam, Oxycodone, and Ropivacaine
- Postoperative Adductor Canal Block GroupTreatment being tested
Participants in this group will receive the standard of care treatment for pain management after TKA, however, the adductor canal block will be placed postoperatively. Participants will be in this group for up to 24 hours
Treatment: Dexamethasone, Acetaminophen, Lyrica, Celebrex, Meloxicam, Oxycodone, and Ropivacaine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pre vs. Postoperative Adductor Canal Block for Total Knee Arthroplasty: Prospective Randomized Trial
- Record updated
- 12 February 2025